29 Jan 2026Open access
Idiopathic Breast Hypertrophy with Hyperprolactinemia in a Postmenopausal Female: A Case Report of Successful Management with Tamoxifen and CabergolinePublisher siteUniversitiesFredrick Chinyama
Active, last published 2026
In streptococcal infections and treatments
Fredrick
Chinyama
Scholar“Research focused on Streptococcal Infections and Treatments and adjacent fields.”
University of Dar es Salaam
Claim Your Profile0
H-index
0
Citations
Fredrick has not officially claimed their profile. If you are Fredrick, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
redrick Chinyama is a researcher working on Streptococcal Infections and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Fredrick's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Streptococcal Infections and Treatments×1Adolescent and Pediatric Healthcare×1
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Dar es SalaamDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works30 May 2025Open access
Adherence to secondary prophylaxis and associated factors among patients with Rheumatic Heart Disease at Jakaya Kikwete Cardiac InstitutePublisher siteResearch Square, Streptococcal Infections and Treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Fredrick?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you